<DOC>
	<DOCNO>NCT02264938</DOCNO>
	<brief_summary>Purpose : To determine drusen morphology ( volume area ) change nonexudative age-related macular degeneration ( AMD ) one year oral supplementation AREDS-like formulation .</brief_summary>
	<brief_title>Drusen Morphology Changes Nonexudative Age-related Degeneration After Oral Antioxidants Supplementation</brief_title>
	<detailed_description>Methods : Patients AREDS category 2 3 AMD prospectively enrol study , randomize receive daily oral supplementation lutein ( 12mg ) + zeaxanthin ( 2mg ) + astaxanthin ( 8mg ) + omega-3 fatty acid ( docosahexaenoic acid [ DHA ] 540mg + eicosapentaenoic acid [ EPA ] 360mg ) + vitamin C ( 40mg ) + vitamin E ( 20mg ) + zinc ( 16mg ) + copper ( 2mg ) , observation one year . ETDRS vision , biomicroscopy , intraocular pressure ( IOP ) , color fundus photography automatic measurement drusen Topcon 3D-OCT 2000 ( Topcon , Tokyo , Japan ) use 6 x 6 mm 3D cube scan protocol , perform patient , baseline 12 month . Automated delineation macular drusen modify investigator evident segmentation error occur .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>AREDS category 2 3 AMD AREDS category 4 AMD ophthalmological disease currently antioxidant supplementation</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>